We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Matthew Campbell

Matthew T Campbell MD, MS

Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dr. Matthew T. Campbell is a medical oncologist practicing in Houston, Texas, and is affiliated with The University of Texas MD Anderson Cancer Center. He is an assistant professor in the Department of Genitourinary Medical Oncology, Division of Cancer Medicine, at MD Anderson, where he conducts clinical and translational research in the area of genitourinary malignancies, with a particular focus on rare tumor types. His translational research interest has focused on the impact of immune checkpoint inhibitors with thermal ablation. Dr. Campbell received his medical degree from Indiana University School of Medicine in Indianapolis, where he also underwent residency training in internal medicine. He completed his clinical fellowship in medical oncology at MD Anderson. He is a member of the AMA, ASCO, and AACR, among other professional organizations.